Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials
The George Institute for Global Health · Translational Research Institute for Metabolism and Diabetes · +16 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
250
total citations
- FWCI
- 77.64
- Percentile
- 100%
- References
- 48
Citations per year
Authors
15- SVSunil V. BadveCorresponding
The George Institute for Global Health
- ABAnika Bilal
Translational Research Institute for Metabolism and Diabetes
- MMMatthew M.Y. Lee
University of Glasgow
- NSNaveed Sattar
University of Glasgow
- HCHertzel C. Gerstein
Population Health Research Institute, Hamilton Health Sciences, McMaster University
Topics & keywords
Topics
Keywords
- Medicine
- Meta-analysis
- Glucagon-like peptide 1 receptor
- Randomized controlled trial
- MEDLINE
- Semaglutide
- Internal medicine
- Type 2 diabetes
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.